| Bioactivity | Enzomenib is an inhibitor of the menin protein encoded by the multiple endocrine neoplasia (MEN) gene. Enzomenib can block the binding of the menin protein to mixed lineage leukemia (MLL) fusion proteins and can be used in the study of hematological malignancies[1]. |
| CAS | 2412555-70-3 |
| Formula | C33H43FN6O3 |
| Molar Mass | 590.73 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Francis Burrows, et al. Treatment of hematological malignancies with inhibitors of menin. US2021/055644. 2022-04-28. |
Enzomenib
CAS: 2412555-70-3 F: C33H43FN6O3 W: 590.73
Enzomenib is an inhibitor of the menin protein encoded by the multiple endocrine neoplasia (MEN) gene. Enzomenib can blo
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.